pubmed-article:4015043 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:4015043 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:4015043 | lifeskim:mentions | umls-concept:C0023467 | lld:lifeskim |
pubmed-article:4015043 | lifeskim:mentions | umls-concept:C1516172 | lld:lifeskim |
pubmed-article:4015043 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:4015043 | pubmed:dateCreated | 1985-8-5 | lld:pubmed |
pubmed-article:4015043 | pubmed:abstractText | Forty patients with previously untreated acute nonlymphocytic leukemia (ANLL) were treated at Saitama Cancer Center between February 1979 and November 1983. Their median age was 43 years (range: 14 to 68 years), 13 patients (32.5%) being 55 years old or older. Twenty-three patients had Auer bodies. Complete remission was achieved in 75.0% of the patients (30/40) with the first line therapy, and in 6 of 7 patients in the second line therapy. Thus, the overall remission rate was 90.0%. The median duration of remission was 14 months and 39% of the patients showed no relapse within 3 years. The median survival for all patients was 26 months and the actuarial 3-year survival rate was 41%. The better results in this series were thought to be due to intensive post-induction reinforcement therapy. | lld:pubmed |
pubmed-article:4015043 | pubmed:language | eng | lld:pubmed |
pubmed-article:4015043 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:4015043 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:4015043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:4015043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:4015043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:4015043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:4015043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:4015043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:4015043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:4015043 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:4015043 | pubmed:issn | 0250-7005 | lld:pubmed |
pubmed-article:4015043 | pubmed:author | pubmed-author:HattoriMM | lld:pubmed |
pubmed-article:4015043 | pubmed:author | pubmed-author:SakuraiMM | lld:pubmed |
pubmed-article:4015043 | pubmed:author | pubmed-author:KanekoYY | lld:pubmed |
pubmed-article:4015043 | pubmed:author | pubmed-author:SampiKK | lld:pubmed |
pubmed-article:4015043 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:4015043 | pubmed:volume | 5 | lld:pubmed |
pubmed-article:4015043 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:4015043 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:4015043 | pubmed:pagination | 293-6 | lld:pubmed |
pubmed-article:4015043 | pubmed:dateRevised | 2006-4-24 | lld:pubmed |
pubmed-article:4015043 | pubmed:meshHeading | pubmed-meshheading:4015043-... | lld:pubmed |
pubmed-article:4015043 | pubmed:meshHeading | pubmed-meshheading:4015043-... | lld:pubmed |
pubmed-article:4015043 | pubmed:meshHeading | pubmed-meshheading:4015043-... | lld:pubmed |
pubmed-article:4015043 | pubmed:meshHeading | pubmed-meshheading:4015043-... | lld:pubmed |
pubmed-article:4015043 | pubmed:meshHeading | pubmed-meshheading:4015043-... | lld:pubmed |
pubmed-article:4015043 | pubmed:meshHeading | pubmed-meshheading:4015043-... | lld:pubmed |
pubmed-article:4015043 | pubmed:meshHeading | pubmed-meshheading:4015043-... | lld:pubmed |
pubmed-article:4015043 | pubmed:meshHeading | pubmed-meshheading:4015043-... | lld:pubmed |
pubmed-article:4015043 | pubmed:meshHeading | pubmed-meshheading:4015043-... | lld:pubmed |
pubmed-article:4015043 | pubmed:meshHeading | pubmed-meshheading:4015043-... | lld:pubmed |
pubmed-article:4015043 | pubmed:meshHeading | pubmed-meshheading:4015043-... | lld:pubmed |
pubmed-article:4015043 | pubmed:meshHeading | pubmed-meshheading:4015043-... | lld:pubmed |
pubmed-article:4015043 | pubmed:meshHeading | pubmed-meshheading:4015043-... | lld:pubmed |
pubmed-article:4015043 | pubmed:meshHeading | pubmed-meshheading:4015043-... | lld:pubmed |
pubmed-article:4015043 | pubmed:meshHeading | pubmed-meshheading:4015043-... | lld:pubmed |
pubmed-article:4015043 | pubmed:meshHeading | pubmed-meshheading:4015043-... | lld:pubmed |
pubmed-article:4015043 | pubmed:articleTitle | Treatment of acute non-lymphocytic leukemia in Saitama Cancer Center. | lld:pubmed |
pubmed-article:4015043 | pubmed:publicationType | Journal Article | lld:pubmed |